These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31221154)

  • 1. Analysing the landscape for prescription to non-prescription reclassification (switch) in Germany: an interview study of committee members and stakeholders.
    Gauld NJ
    BMC Health Serv Res; 2019 Jun; 19(1):404. PubMed ID: 31221154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicines reclassification from a pharmaceutical industry perspective: An international qualitative study.
    Gauld NJ; Kelly FS; Emmerton LM; Kurosawa N; Bryant LJM; Buetow SA
    Res Social Adm Pharm; 2019 Apr; 15(4):387-394. PubMed ID: 30917892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why does increasing public access to medicines differ between countries? Qualitative comparison of nine countries.
    Gauld N; Bryant L; Emmerton L; Kelly F; Kurosawa N; Buetow S
    J Health Serv Res Policy; 2015 Oct; 20(4):231-9. PubMed ID: 26152909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why are self-medication opportunities limited in Austria? An interview study and comparison with other countries.
    Gauld NJ; Baumgärtel CA; Buetow SA
    PLoS One; 2021; 16(1):e0245504. PubMed ID: 33493218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Widening consumer access to medicines: a comparison of prescription to non-prescription medicine switch in Australia and New Zealand.
    Gauld NJ; Kelly FS; Emmerton LM; Buetow SA
    PLoS One; 2015; 10(3):e0119011. PubMed ID: 25785589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Australian pharmacy perspectives on increasing access to medicines through reclassification.
    Mey A; King M; Kelly F; Grant G; Townshend J; Baumann-Birkbeck L; Woods P; Hope D
    J Health Serv Res Policy; 2019 Apr; 24(2):81-90. PubMed ID: 30352516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barriers to positive policy change that aims to increase access to medicines through reclassification: the case of oseltamivir in New Zealand.
    Shaw JP; Gauld N; Kelly F
    Int J Pharm Pract; 2016 Feb; 24(1):6-12. PubMed ID: 26154432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new model of prescription to nonprescription reclassification: the calcipotriol case study.
    Gauld N; Emmerton L; Kelly F; Buetow S
    Clin Ther; 2012 Jun; 34(6):1324-32. PubMed ID: 22578311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Australian pharmacists: ready for increased non-prescription medicines reclassification.
    Hope DL; Woods P; Mey A; Kelly FS; Townshend J; Baumann-Birkbeck LM; King MA
    Int J Pharm Pract; 2020 Jun; 28(3):246-254. PubMed ID: 31913550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is Reclassification of the Oral Contraceptive Pill from Prescription to Pharmacist-Only Cost Effective? Application of an Economic Evaluation Approach to Regulatory Decisions.
    Gumbie M; Parkinson B; Cutler H; Gauld N; Mumford V
    Pharmacoeconomics; 2019 Aug; 37(8):1049-1064. PubMed ID: 31069781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of non-prescription medicines during lactation: A qualitative study of community pharmacists' attitudes and perspectives.
    Sim TF; Hattingh HL; Sherriff J; Tee LBG
    Res Social Adm Pharm; 2018 May; 14(5):464-470. PubMed ID: 28624292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacists' adoption into practice of newly reclassified medicines from diverse therapeutic areas in Scotland: a quantitative study of factors associated with decision-making.
    Paudyal V; Hansford D; Cunningham S; Stewart D
    Res Social Adm Pharm; 2014; 10(1):88-105. PubMed ID: 23665077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacy Medicines Not Subject to Medical Prescription in Portugal: An Underused Access Opportunity?].
    Martins AP; Gonçalves E; Marcelo A; Vilão S; Aranda Silva J
    Acta Med Port; 2016 Sep; 29(9):542-548. PubMed ID: 28060692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community pharmacists' adoption of medicines reclassified from prescription-only status: a systematic review of factors associated with decision making.
    Paudyal V; Hansford D; Cunningham S; Stewart D
    Pharmacoepidemiol Drug Saf; 2012 Apr; 21(4):396-406. PubMed ID: 22362493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness of Reclassifying Triptans in Australia: Application of an Economic Evaluation Approach to Regulatory Decisions.
    Parkinson B; Gumbie M; Cutler H; Gauld N; Mumford V; Haywood P
    Value Health; 2019 Mar; 22(3):293-302. PubMed ID: 30832967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Civil society engagement in multi-stakeholder dialogue: a qualitative study exploring the opinions and perceptions of MeTA members.
    Buckland-Merrett GL; Kilkenny C; Reed T
    J Pharm Policy Pract; 2017; 10():5. PubMed ID: 28070340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-prescription medicines: current issues in Australian community pharmacy.
    Tan AC; Emmerton L
    Int J Pharm Pract; 2009 Aug; 17(4):207-13. PubMed ID: 20217945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving access to medicines via the Health Impact Fund in India: a stakeholder analysis.
    McMullan P; Ajay VS; Srinivas R; Bhalla S; Prabhakaran D; Banerjee A
    Glob Health Action; 2018; 11(1):1434935. PubMed ID: 29495950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicine reclassification processes and regulations for proper use of over-the-counter self-care medicines in Japan.
    Nomura K; Kitagawa Y; Yuda Y; Takano-Ohmuro H
    Risk Manag Healthc Policy; 2016; 9():173-83. PubMed ID: 27555801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.